Displaying 26–50 of 223 results for Paul Thomas, Managing Editor

Sort By Relevance Sort By Date
1 2 3 4 5 ...9

The Need for New Models in Identifying New Molecules

(Article)

Probabilistic rather than deterministic modeling is essential, says Quintiles’ Davis Walp.

The Good Fight: The Plight of Pharma's Middle Managers

(Article)

Middle managers in pharma today have a tough, thankless job—but someone’s got to do it, and many do it well.

Shoring Up Pharma’s Middle Management

(Article)

Organizations with built-in risk management frameworks allow middle managers to thrive, says Scott Chizzo, Maxiom Group’s president and chief consultant, in this exclusive interview.

Tales from the Middle

(Article)

Pharma's middle managers carry on despite a "damned if we do, damned if we don't" environment.

Managing Change Management in Pharma: A Talk with Bill Wilder

(Article)

People generally don’t resist change, says the Life Cycle Institute's Bill Wilder. “They resist being changed when they don't know why.”

Creative and Cautious: How Pharma’s Managers-Once-Removed Can Claim Relevance

(Article)

Industry consultant Jane Chin examines what makes the jobs of pharma’s middle managers so tough, and how they can succeed against the odds.

Pharma Asset Management: Sizing Up the Global Secondary Market

(Article)

As pharma and biopharma companies deal with turbulent times, they look to a more sophisticated (and even real-time) secondary market to help manage equipment and assets. An industry expert surveys the scene, and provides smart shopping and selling advice, software

New Technologies: Continuous Effluent Decontamination for Pharma Facilities

(Article)

Steris Finn-Aqua has developed a new technology for the automatic decontamination of pharma/biopharma effluent.

Bioprocess Filtration: Debating Post-sterilization Integrity Testing

(Article)

At PDA 2011, at issue was whether current EMA guidelines are rational or risky; also, a look at new filtration products on the market.

PharmaView: What's the Prescription for Painkiller Nation?

(Article)

With FDA and the Obama administration on alert, it is drug manufacturers' turn to address a crisis.

On Developing an OpEx Culture at Elan

(Article)

Elan's head of manufacturing, Kevin Brady, talks about what works, and why.

What’s Your True Green?

(Article)

If it can’t be measured, it can’t be green; leading manufacturers are turning to advanced metrics to show just how sustainable their products, processes, and plants really are.

PharmaView: What’s Your Saving Story?

(Article)

There’s nothing like a good tale of frugality to make your day.

Abbott: Building a Stable Foundation for Continuous Improvement

(Article)

Abbott's Continuous Improvement Manager shares best practices on how to prepare an organization for Lean and Six Sigma projects.

Who Owns Your Data?

(Article)

IT, Engineering, Lab? The answer under a consolidated system should be no one and everyone, says Patni’s Jim Macdonell.

PharmaView: Should Pharma Fear the Supply Chain of the Future?

(Article)

As paradigms shift, we also need paradigm expansion.

Can Drug Manufacturers Find Business Benefits in Product Serialization?

(Article)

John Danese, Oracle’s Director of Product Strategy, provides an update on the electronic pedigree landscape and how manufacturers are doing in their serialization efforts.

Pedigree Adopters Play the Waiting Game

(Article)

Manufacturers’ electronic pedigree and serialization efforts creep ahead, slowed by FDA’s inaction.

2011: Progress on the Pedigree Front?

(Article)

Maxiom Group’s Scott Dicks answers our questions about whether drug manufacturers are moving ahead with electronic pedigree programs, software

Onsite and Online, Interphex Attracting Visitors

(Article)

The annual spring tradeshow has reenergized itself by building a year-round online presence.

On the Brink of Burnout

(Article)

Our annual survey results say you’ve just about had enough. Will 2011 be the year things turn in your favor?

Pharma Jobs 2011: Curb Your Enthusiasm, and Ego

(Article)

There’s still not enough evidence for full-fledged optimism, says a leading recruiter.

Production Planning Amid Uncertainty

(Article)

Production planning is hard enough, but when uncertainty peaks, the challenges are compounded.

Can Personalized Medicine Be Automated, and Accelerated?

(Article)

Customized, cheaper immunotherapies could be delivered to patients within a month, says Argos Therapeutics’ head of manufacturing.

Critical Parameters of Managing Contract Risks

(Article)

Three experts share their views and best practices of risk-based contract partnerships.

Sort By Relevance Sort By Date
1 2 3 4 5 ...9